Published Date: 17 Feb 2023
More than 2.5 million agricultural workers help maintain America's food supply. They play an important role in the economy, but their work is difficult and often dangerous.
Read Full NewsTake 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 6, 2026.
A new comparison study of patients with autoimmune diseases reported high rates of anxiety and depression, with notable differences in when psychiatric symptoms emerged relative to disease onset.
A real-world study showed that cladribine tablets were associated with greater treatment persistence and lower health care costs in patients with multiple sclerosis compared with other common therapies.
The single-arm CLAD-MAPET study is evaluating whether cladribine tablets reduce microglial activation, captured by [F-18]PBR06-PET, in patients with MS experiencing progression without relapse or MRI activity on anti-CD20 therapy.
Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD
The HCPFive: Top News for Healthcare Providers from the Week of 02/01
HCPLive 5 Stories in Under 5: Week of 02/01
1.
Patients value communication skills from cancer surgeons across six key areas, according to research
2.
AI is equally capable of reading breast cancer scans as human radiologists.
3.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
4.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
5.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
1.
Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape
2.
Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment
3.
Beyond the Battle: Navigating Life After Cancer
4.
Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment
5.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation